cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.24433972
title: Supplementary Material for: Prenatal Risk Factors and Outcomes of Pseudoamniotic Band Sequence Following Fetoscopic Laser Surgery, Systematic Review and Meta-analysis

description: Introduction: To investigate prenatal risk factors and perinatal outcomes for pregnancies involving pseudoamniotic band sequence (PABS) after fetoscopic laser surgery (FLS) for twin-to-twin transfusion syndromes (TTTS) and compare outcomes between those undergoing fetoscopic band release vs. not. Methods: We conducted a systematic search of PubMed, Scopus, and Web of Science on studies reporting PABS following FLS for TTTS. A meta-analysis of pooled proportions was conducted. Results: There were 16 studies covering 47 pregnancies complicated by PABS following FLS, mostly case series and case reports. The incidence of PABS was 2%, with the recipient twin affected in 94% of the cases. Pregnancies complicated by PABS were associated with inter-twin septostomy in 32% and chorioamniotic separation (CAS) in 90%. The mean gestational age (GA) at FLS and delivery were 17.7 and 30.9 weeks respectively. Preterm premature rupture of membranes (PPROM) happened in 62% of pregnancies. The risk of preterm birth (PTB) &lt;34 weeks, &lt;32 weeks, and &lt;28 weeks were 94%, 67%, and 31%, respectively. There were 41% fetal demises and 64% live births among the affected fetuses. Results of fetoscopic band release versus not were comparable, including GA at delivery, PPROM, and PTB at 32 weeks. It was noted that the likelihood of PTB by 28 weeks (67% vs 23%) and fetal death (50% vs 39%) were higher in the band release group. It was similar between groups in terms of postnatal amputation. Conclusion: PABS causes amputations or fetal death in more than one-third of cases. Pregnancies with an inter-twin septostomy, CAS, advanced TTTS staging, and early GA are more likely to experience PABS. In addition, more than a third of FLS-treated TTTS resulted in PTB and PPROM. PABS cases with prenatal band release showed higher rates of PTB and fetal death, but the data were from small, heterogeneous studies.
DOI: 10.6084/m9.figshare.24433975
title: Supplementary Material for: Prenatal Risk Factors and Outcomes of Pseudoamniotic Band Sequence Following Fetoscopic Laser Surgery, Systematic Review and Meta-analysis

description: Introduction: To investigate prenatal risk factors and perinatal outcomes for pregnancies involving pseudoamniotic band sequence (PABS) after fetoscopic laser surgery (FLS) for twin-to-twin transfusion syndromes (TTTS) and compare outcomes between those undergoing fetoscopic band release vs. not. Methods: We conducted a systematic search of PubMed, Scopus, and Web of Science on studies reporting PABS following FLS for TTTS. A meta-analysis of pooled proportions was conducted. Results: There were 16 studies covering 47 pregnancies complicated by PABS following FLS, mostly case series and case reports. The incidence of PABS was 2%, with the recipient twin affected in 94% of the cases. Pregnancies complicated by PABS were associated with inter-twin septostomy in 32% and chorioamniotic separation (CAS) in 90%. The mean gestational age (GA) at FLS and delivery were 17.7 and 30.9 weeks respectively. Preterm premature rupture of membranes (PPROM) happened in 62% of pregnancies. The risk of preterm birth (PTB) &lt;34 weeks, &lt;32 weeks, and &lt;28 weeks were 94%, 67%, and 31%, respectively. There were 41% fetal demises and 64% live births among the affected fetuses. Results of fetoscopic band release versus not were comparable, including GA at delivery, PPROM, and PTB at 32 weeks. It was noted that the likelihood of PTB by 28 weeks (67% vs 23%) and fetal death (50% vs 39%) were higher in the band release group. It was similar between groups in terms of postnatal amputation. Conclusion: PABS causes amputations or fetal death in more than one-third of cases. Pregnancies with an inter-twin septostomy, CAS, advanced TTTS staging, and early GA are more likely to experience PABS. In addition, more than a third of FLS-treated TTTS resulted in PTB and PPROM. PABS cases with prenatal band release showed higher rates of PTB and fetal death, but the data were from small, heterogeneous studies.
DOI: 10.6084/m9.figshare.24433975.v1
title: Supplementary Material for: Prenatal Risk Factors and Outcomes of Pseudoamniotic Band Sequence Following Fetoscopic Laser Surgery, Systematic Review and Meta-analysis

description: Introduction: To investigate prenatal risk factors and perinatal outcomes for pregnancies involving pseudoamniotic band sequence (PABS) after fetoscopic laser surgery (FLS) for twin-to-twin transfusion syndromes (TTTS) and compare outcomes between those undergoing fetoscopic band release vs. not. Methods: We conducted a systematic search of PubMed, Scopus, and Web of Science on studies reporting PABS following FLS for TTTS. A meta-analysis of pooled proportions was conducted. Results: There were 16 studies covering 47 pregnancies complicated by PABS following FLS, mostly case series and case reports. The incidence of PABS was 2%, with the recipient twin affected in 94% of the cases. Pregnancies complicated by PABS were associated with inter-twin septostomy in 32% and chorioamniotic separation (CAS) in 90%. The mean gestational age (GA) at FLS and delivery were 17.7 and 30.9 weeks respectively. Preterm premature rupture of membranes (PPROM) happened in 62% of pregnancies. The risk of preterm birth (PTB) &lt;34 weeks, &lt;32 weeks, and &lt;28 weeks were 94%, 67%, and 31%, respectively. There were 41% fetal demises and 64% live births among the affected fetuses. Results of fetoscopic band release versus not were comparable, including GA at delivery, PPROM, and PTB at 32 weeks. It was noted that the likelihood of PTB by 28 weeks (67% vs 23%) and fetal death (50% vs 39%) were higher in the band release group. It was similar between groups in terms of postnatal amputation. Conclusion: PABS causes amputations or fetal death in more than one-third of cases. Pregnancies with an inter-twin septostomy, CAS, advanced TTTS staging, and early GA are more likely to experience PABS. In addition, more than a third of FLS-treated TTTS resulted in PTB and PPROM. PABS cases with prenatal band release showed higher rates of PTB and fetal death, but the data were from small, heterogeneous studies.
DOI: 10.5281/zenodo.10040110
title: Dataset related to article "Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study "

description: This record contains raw data related to article "Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study"
Abstract
The aim of this study was to evaluate the clinical outcomes of a large series of brain metastatic renal cell carcinoma (BMRCC) patients treated in three Italian centers.
Methods: A total of 120 BMRCC patients with a total of 176 lesions treated were evaluated. Patients received surgery plus postoperative HSRS, single-fraction SRS, or hypofractionated SRS (HSRS). Local control (LC), brain distant failure (BDF), overall survival (OS), toxicities, and prognostic factors were assessed.
Results: The median follow-up time was 77 months (range 16-235 months). Surgery plus HSRS was performed in 23 (19.2%) cases, along with SRS in 82 (68.3%) and HSRS in 15 (12.5%). Seventy-seven (64.2%) patients received systemic therapy. The main total dose and fractionation used were 20-24 Gy in single fraction or 32-30 Gy in 4-5 daily fractions. Median LC time and 6 month and 1, 2 and 3 year LC rates were nr, 100%, 95.7% ± 1.8%, 93.4% ± 2.4%, and 93.4% ± 2.4%. Median BDF time and 6 month and 1, 2 and 3 year BDF rates were n.r., 11.9% ± 3.1%, 25.1% ± 4.5%, 38.7% ± 5.5%, and 44.4% ± 6.3%, respectively. Median OS time and 6 month and 1, 2 and 3 year OS rates were 16 months (95% CI: 12-22), 80% ± 3.6%, 58.3% ± 4.5%, 30.9% ± 4.3%, and 16.9% ± 3.6, respectively. No severe neurological toxicities occurred. Patients with a favorable/intermediate IMDC score, a higher RCC-GPA score, an early occurrence of BMs from primary diagnosis, absence of EC metastases, and a combined local treatment (surgery plus adjuvant HSRS) had a better outcome.
Conclusions: SRS/HSRS is proven to be an effective local treatment for BMRCC. A careful evaluation of prognostic factors is a valid step to manage the optimal therapeutic strategy for BMRCC patients.
DOI: 10.5281/zenodo.10040109
title: Dataset related to article "Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study "

description: This record contains raw data related to article "Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study"
Abstract
The aim of this study was to evaluate the clinical outcomes of a large series of brain metastatic renal cell carcinoma (BMRCC) patients treated in three Italian centers.
Methods: A total of 120 BMRCC patients with a total of 176 lesions treated were evaluated. Patients received surgery plus postoperative HSRS, single-fraction SRS, or hypofractionated SRS (HSRS). Local control (LC), brain distant failure (BDF), overall survival (OS), toxicities, and prognostic factors were assessed.
Results: The median follow-up time was 77 months (range 16-235 months). Surgery plus HSRS was performed in 23 (19.2%) cases, along with SRS in 82 (68.3%) and HSRS in 15 (12.5%). Seventy-seven (64.2%) patients received systemic therapy. The main total dose and fractionation used were 20-24 Gy in single fraction or 32-30 Gy in 4-5 daily fractions. Median LC time and 6 month and 1, 2 and 3 year LC rates were nr, 100%, 95.7% ± 1.8%, 93.4% ± 2.4%, and 93.4% ± 2.4%. Median BDF time and 6 month and 1, 2 and 3 year BDF rates were n.r., 11.9% ± 3.1%, 25.1% ± 4.5%, 38.7% ± 5.5%, and 44.4% ± 6.3%, respectively. Median OS time and 6 month and 1, 2 and 3 year OS rates were 16 months (95% CI: 12-22), 80% ± 3.6%, 58.3% ± 4.5%, 30.9% ± 4.3%, and 16.9% ± 3.6, respectively. No severe neurological toxicities occurred. Patients with a favorable/intermediate IMDC score, a higher RCC-GPA score, an early occurrence of BMs from primary diagnosis, absence of EC metastases, and a combined local treatment (surgery plus adjuvant HSRS) had a better outcome.
Conclusions: SRS/HSRS is proven to be an effective local treatment for BMRCC. A careful evaluation of prognostic factors is a valid step to manage the optimal therapeutic strategy for BMRCC patients.
DOI: 10.5281/zenodo.10040167
title: Annotations for NP13 proceedings paper of Banzina & Niebuhr: How to pause in charismatic speeches: A case study of Barack Obama

description: TextGrid file used in the above specified study as well as a readme document that includes a link to the corresponding/analyzed YouTube video and the time stamps from where to where the audio was analyzed. Both should enable users to (a) extract the audio from the YouTube video and (b) time align the extracted audio with the TextGrid file. Note that the PRAAT software tool (praat.org) is required to open TextGrid files properly.
DOI: 10.5281/zenodo.10040166
title: Annotations for NP13 proceedings paper of Banzina & Niebuhr: How to pause in charismatic speeches: A case study of Barack Obama

description: TextGrid file used in the above specified study as well as a readme document that includes a link to the corresponding/analyzed YouTube video and the time stamps from where to where the audio was analyzed. Both should enable users to (a) extract the audio from the YouTube video and (b) time align the extracted audio with the TextGrid file. Note that the PRAAT software tool (praat.org) is required to open TextGrid files properly.
DOI: 10.5281/zenodo.10040158
title: Dataset related to article "EUS-guided gastroenterostomy using a novel electrocautery lumen apposing metal stent for treatment of gastric outlet obstruction (with video)"

description: This record contains raw data related to article "EUS-guided gastroenterostomy using a novel electrocautery lumen apposing metal stent for treatment of gastric outlet obstruction (with video)"
Abstract
Background and aim: Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) for the treatment of gastric outlet obstruction (GOO) has been actually performed only with one type of electrocautery lumen-apposing metal stents (EC-LAMS). We aimed to evaluate the safety, technical and clinical effectiveness of EUS-GE using a newly available EC-LAMS in patients with malignant and benign GOO.
Materials and methods: Consecutive patients who underwent EUS-GE for GOO using the new EC-LAMS at five endoscopic referral centers were retrospectively evaluated. Clinical efficacy was determined utilizing the Gastric Outlet Obstruction Scoring System (GOOSS).
Results: Twenty-five patients (64% male, mean age 68.7 ± 9.3 years) met the inclusion criteria; 21 (84%) had malignant etiology. Technically, EUS-GE was successful in all patients, with a mean procedural time of 35 ± 5 min. Clinical success was 68% at 7 days and 100% at 30 days. The mean time to resume oral diet was 11.4 ± 5.8 h, with an improvement of at least one point of GOOSS score observed in all patients. The median hospital stay was 4 days. No procedure-related adverse events occurred. After a mean follow-up of 7.6 months (95% CI 4.6-9.2), no stent dysfunctions were observed.
Conclusion: This study suggests EUS-GE can be performed safely and successfully using the new EC-LAMS. Future large multicenter prospective studies are needed to confirm our preliminary data.
DOI: 10.5281/zenodo.10040159
title: Dataset related to article "EUS-guided gastroenterostomy using a novel electrocautery lumen apposing metal stent for treatment of gastric outlet obstruction (with video)"

description: This record contains raw data related to article "EUS-guided gastroenterostomy using a novel electrocautery lumen apposing metal stent for treatment of gastric outlet obstruction (with video)"
Abstract
Background and aim: Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) for the treatment of gastric outlet obstruction (GOO) has been actually performed only with one type of electrocautery lumen-apposing metal stents (EC-LAMS). We aimed to evaluate the safety, technical and clinical effectiveness of EUS-GE using a newly available EC-LAMS in patients with malignant and benign GOO.
Materials and methods: Consecutive patients who underwent EUS-GE for GOO using the new EC-LAMS at five endoscopic referral centers were retrospectively evaluated. Clinical efficacy was determined utilizing the Gastric Outlet Obstruction Scoring System (GOOSS).
Results: Twenty-five patients (64% male, mean age 68.7 ± 9.3 years) met the inclusion criteria; 21 (84%) had malignant etiology. Technically, EUS-GE was successful in all patients, with a mean procedural time of 35 ± 5 min. Clinical success was 68% at 7 days and 100% at 30 days. The mean time to resume oral diet was 11.4 ± 5.8 h, with an improvement of at least one point of GOOSS score observed in all patients. The median hospital stay was 4 days. No procedure-related adverse events occurred. After a mean follow-up of 7.6 months (95% CI 4.6-9.2), no stent dysfunctions were observed.
Conclusion: This study suggests EUS-GE can be performed safely and successfully using the new EC-LAMS. Future large multicenter prospective studies are needed to confirm our preliminary data.
DOI: 10.11588/data/r9ikcf
title: SimTool-SynBench

description: The SimTool is a toolset to simulate soft tissue deformation during resection surgery. The proposed toolset is an assimilation of 3D packages in Python and Unreal Engine 4 (UE4) with Nvidia Flex integration, which make it possible to adapt the dataset for more applications. The SynBench is a synthetic definable object benchmark that includes the ground truth between two point sets as well as various challenges, namely, deformation levels, noise, outlier, and data incompleteness.
DOI: 10.5281/zenodo.10015169
title: Integrated PF-ILD scRNA-seq atlas

description: Processed counts object of the integrated PF-ILD atlas from publicly available scRNA-seq datasets.
DOI: 10.5281/zenodo.10015168
title: Integrated PF-ILD scRNA-seq atlas

description: Processed counts object of the integrated PF-ILD atlas from publicly available scRNA-seq datasets.
DOI: 10.5281/zenodo.6937616
title: Helsinki Tomography Challenge 2022 open tomographic dataset (HTC 2022)

description: This dataset is primarily designed for the Helsinki Tomography Challenge 2022 (HTC 2022), but it can be used for generic algorithm research and development in limited angle tomography. The dataset contains 2D tomographic measurements, i.e. sinograms and the affiliated metadata containing measurement geometry and other specifications. The sinograms have already been pre-processed with background and flat-field corrections, and compensated for a slightly misaligned center of rotation in the cone-beam computed tomography scanner. The log-transforms from intensity measurements to attenuation data have also been already computed. The data has been stored as MATLAB structs and saved in .mat file format. The purpose of HTC 2022 is to develop algorithms for limited angle tomography. The challenge data consists of tomographic measurements of a set of plastic phantoms with a diameter of 7 cm and with holes of differing shapes cut into them. The data are arranged into seven different difficulty levels, labeled 1-7, with each level containing three different phantoms, labeled A-C. As the difficulty level increases, the number of holes increases and their shapes become increasingly complex. Furthermore, the view angle is reduced as the difficulty level increases, starting with a 90 degree field of view at level 1, and reducing by 10 degrees at each increasing level of difficulty. The current available dataset also contains five training phantoms with full angular data. These is designed to facilitate algorithm development and benchmarking for the challenge itself. Four of the phantoms contain holes. These are labeled ta, tb, tc, and td. A fifth phantom is a solid disc with no holes. We encourage subsampling these datasets to create limited data sinograms and comparing the reconstruction results to the ground truth obtainable from the full-data sinograms. The full data for all the phantoms will be released after the Helsinki Tomography Challenge 2022 has ended. All measurements were conducted at the Industrial Mathematics Computed Tomography Laboratory at the University of Helsinki.
DOI: 10.5281/zenodo.10040217
title: A Brief Review of Multiple Phytochemical Activities on Blackberry Leaves

description: Blackberry leaves are not considered functional foods, despitethe fact that they also have activesubstances with the potential to improve health. Blackberry fruits are recognised as functional foods. Blackberry (Rubus sp.) fruit has a strong antioxidant capacity and other biological activities becauseit includes significant levels of anthocyanins and other phenoliccompounds, primarily flavonolsand ellagitannins. It is well recognized that genetics, growingenvironments, and maturation affect the content and quantities of phenolic compounds in blackberries. Despitewhat is currentlyknown about theirchemistry, specialized studieson the health advantages of blackberry phenoliccomponents, metabolism, bioavailability, and mechanism by which they bestow health advantages is rare. Age-related neurological diseases are protected against by the phenolic compoundsin blackberries. Low-density lipoprotein and liposomal oxidation can be inhibited in vitro, alongwith illnesses and bone loss in vivo. Extracts of blackberries have also acted as an inhibitor of tumor- promoting factors and cell signalling pathways to exhibitantimutagenic actions in vitro and in animals. Blackberry phenolic compounds' anti-obesity, anti-diabetic, anti-microbial, and anti- inflammatory effects, however, require investigation. Likewise, investigations that clarify the physiologically effective quantities of phenolic chemicals found in blackberries in vivo are required.
DOI: 10.5281/zenodo.10040216
title: A Brief Review of Multiple Phytochemical Activities on Blackberry Leaves

description: Blackberry leaves are not considered functional foods, despitethe fact that they also have activesubstances with the potential to improve health. Blackberry fruits are recognised as functional foods. Blackberry (Rubus sp.) fruit has a strong antioxidant capacity and other biological activities becauseit includes significant levels of anthocyanins and other phenoliccompounds, primarily flavonolsand ellagitannins. It is well recognized that genetics, growingenvironments, and maturation affect the content and quantities of phenolic compounds in blackberries. Despitewhat is currentlyknown about theirchemistry, specialized studieson the health advantages of blackberry phenoliccomponents, metabolism, bioavailability, and mechanism by which they bestow health advantages is rare. Age-related neurological diseases are protected against by the phenolic compoundsin blackberries. Low-density lipoprotein and liposomal oxidation can be inhibited in vitro, alongwith illnesses and bone loss in vivo. Extracts of blackberries have also acted as an inhibitor of tumor- promoting factors and cell signalling pathways to exhibitantimutagenic actions in vitro and in animals. Blackberry phenolic compounds' anti-obesity, anti-diabetic, anti-microbial, and anti- inflammatory effects, however, require investigation. Likewise, investigations that clarify the physiologically effective quantities of phenolic chemicals found in blackberries in vivo are required.
DOI: 10.5255/ukda-sn-856712
title: Recommendations Made by International Election Observation Missions in Ghana, Kenya, Liberia, Nigeria, and Uganda, 2002 - 2018

description: This dataset compiles recommendations made by international election observation missions (EOMs) in five countries (Ghana, Kenya, Nigeria, Liberia, and Uganda) between 2002 and 2018. It is based upon reports produced by the following organisations: the European Union, the Commonwealth, the Carter Centre, the National Democratic Institute, the International Republican Institute, the African Union, the Electoral Institute for Sustainable Democracy in Africa. Reports were accessed through the ACE Election Observation Portal, or (when missing) from the relevant organisation's website. The dataset contains the following information for each recommendation: 1. Identifying features (including election year, country, and observer group); 2. Characteristics of the recommendation (coding based upon Martinez i Coma, Nai & Norris, Democratic DIffusion: How Regional Organizations Strengthen Electoral Integrity, Policy Report, December 2016). * Stage, * Scope, * Specificity, * Timing, * Actors, * Mechanisms, * Changes. NB: two options were added to the characteristics framework developped by Martinez i Coma et al.: ""international community"" for the Actor variable; and ""behaviour change"" for the ""Mechanism"" variable; 3. Extent of implementation (assessed based upon subsequent EOM reports, additional desk research, and short fieldwork when necessary). This dataset was produced between 2019 and 2020 by Eloïse Bertrand, with support from Susan Dodsworth and Jamie Hitchen. This was done as part of a project funded by the Westminster Foundation for Democracy (WFD), with input from Tanja Hollstein and Graeme Ramshaw.